Synata Bio Overview
- Founded
-
2015
- Status
-
Private
- Employees
-
25
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$606K
- Investors
-
1
Synata Bio General Information
Description
Developer of a fermentation technology designed to process synthesis gas from multiple sources into products. The company's technology is a non-GMO biocatalyst that harmonizes all feedstocks with carbon utilization and an efficient gas-to-liquids platform, enabling chemical companies to have access to a sustainable technology to produce primary alcohols.
Contact Information
Website
www.synatabio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Industrial Chemicals
Other Industries
Environmental Services (B2B)
Primary Office
- 4575 Weaver Parkway
- Suite 100
- Warrenville, IL 60555
- United States
+1 (312) 000-0000
Synata Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC | 01-Feb-2021 | $606K | Completed | Startup | ||
| 3. Buyout/LBO | 19-Oct-2020 | 0000 | Completed | Startup | ||
| 2. Early Stage VC (Series A) | 30-Jan-2018 | $30M | $77M | 0000 | Completed | Startup |
| 1. Early Stage VC | 11-Apr-2017 | $47M | $47M | Completed | Startup |
Synata Bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | 00,000,000 | 00.000000 | 00.00 | 00 | 00 | 00 | 00 | 00.000 |
Synata Bio Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Synata Bio Patents
Synata Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20200199519-A1 | System and method for concentrating suspended solids prior to removal | Pending | 31-Jul-2017 | 000000000 | |
| AU-2018309697-A1 | System and method for concentrating suspended solids prior to removal | Inactive | 31-Jul-2017 | 000000000 | |
| CA-3071542-A1 | System and method for concentrating suspended solids prior to removal | Pending | 31-Jul-2017 | 000000000 | |
| AU-2017382765-A1 | Methods and systems using ionophores to control contamination in fermentation of gaseous substrates | Inactive | 22-Dec-2016 | 000000000 | |
| CA-3047764-A1 | Methods and systems using ionophores to control contamination in fermentation of gaseous substrates | Pending | 22-Dec-2016 | C12P7/065 |
Synata Bio Executive Team (5)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Macy Stoneback | Executive Officer | ||
| Steve Sloma | Vice President of Finance & Commercial Development | ||
| Steven Kloos Ph.D | President & Board Member | ||
| Jeremy Patt Ph.D | Advisor |
Synata Bio Board Members (5)
| Name | Representing | Role | Since |
|---|---|---|---|
| Alan Henderson | Synata Bio | Board Member | 000 0000 |
| Jay Kouba Ph.D | True North Venture Partners | Board Member | 000 0000 |
| Matthew Ahearn | True North Venture Partners | Board Member | 000 0000 |
| Michael Ahearn JD | True North Venture Partners | Chairman | 000 0000 |
| Steven Kloos Ph.D | Self | President & Board Member | 000 0000 |
Synata Bio Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Synata Bio Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| True North Venture Partners | Venture Capital | Minority | 000 0000 | 000000 0 |
Synata Bio Investments & Acquisitions (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000000 00000 | 05-Dec-2016 | 0000000000 | 000.00 | Energy Production | |
| Abengoa Bioenergy Biomass (Hugoton cellulosic ethanol plant) | 30-Nov-2016 | Corporate Asset Purchase | 000.00 | Buildings and Property |